Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
/in Breast Cancer, Dendritic Cells, International PublicationsSafety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
/in Breast Cancer, Dendritic Cells, International PublicationsImpact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
/in Breast Cancer, Dendritic Cells, International Publications5-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.
/in Dendritic Cells, International Publications, Malignant MelanomaAssociation of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.
/in Dendritic Cells, Glioblastoma, International PublicationsDendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic CancerImmune effects by selective heating of membrane rafts of cancer-cells.
/in Hyperthermia, International PublicationsRecent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaA feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer